NCT02305563 2021-09-16An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid LeukemiaBristol-Myers SquibbPhase 1/2 Terminated70 enrolled 36 charts